Patent ID: 9637798
Date: 2017-05-02
CPC Classifications: A61K,C12Q,C12Y,G01N,Y02A

Claim:
1. A method of treating a cancer in a subject, comprising: obtaining a sample from the subject; assaying the sample to determine the expression levels of Base Excision Repair (BER) pathway markers comprising Apex 1, Apex 2, and MPG relative to levels found in a non-tumor cell, treating the subject when a low level of Apex 1, a low level of Apex 2, and a high level of MPG is found, wherein the low level of Apex 1 is between 1.300 and 3.600, the low level of Apex 2 is between 0 and 0.400 and the high level of MPG is between 1.200 and 2.800.